Clinical chemistry score more effective in identifying ACS risk | Study links SGLT1 genetic mutation to reduced diabetes risk | Study evaluates source of hospital-acquired bloodstream infections
ADVERTISEMENT
October 16, 2018
AACC SmartBrief
SIGN UP ⋅   FORWARD
Top Story
Clinical chemistry score more effective in identifying ACS risk
A clinical chemistry score that combined high-sensitivity cardiac troponin and glucose results with estimated glomerular filtration rate performed better in terms of sensitivity and specificity than high-sensitivity cardiac troponin results alone in stratifying risk among emergency room patients suspected of having acute coronary syndrome, a study found. Adopting the laboratory score could lead to better lab reporting and analytics needed for patient examination, researchers said.
Clinical Laboratory News (10/2018) 
LinkedIn Twitter Facebook Google+ Email
Brown Executive Master in Science & Tech
Brown University's Executive Master in Science and Technology Leadership is a 16-month program combining the business fundamentals of an MBA with personalized leadership for mid-career professionals in science, technology and engineering. Learn more.
ADVERTISEMENT
Science Briefs
Study links SGLT1 genetic mutation to reduced diabetes risk
A study in the Journal of the American College of Cardiology showed that individuals who had a genetic mutation in the gut that reduced SGLT1 function were at a lower risk of developing type 2 diabetes, as well as a lower risk of heart failure, obesity and mortality. Researchers evaluated data from 8,478 participants and found those with the genetic mutation also had a reduced glucose uptake, compared with those without the mutation.
Diabetes (UK) (10/10) 
LinkedIn Twitter Facebook Google+ Email
Study evaluates source of hospital-acquired bloodstream infections
A study in the journal Nature Medicine showed that bloodstream infections acquired by patients during a hospital stay can be traced to their own bodies, specifically to their large intestines. The findings were based on data from blood and stool samples of 30 patients who acquired bloodstream infections after undergoing a bone marrow transplant at Stanford Hospital between early 2015 and 2017.
United Press International (10/15) 
LinkedIn Twitter Facebook Google+ Email
UChicago Masters in Biomedical Informatics
Start your Master of Science in Biomedical Informatics at UChicago this spring. You'll build informatics solutions that address today's healthcare challenges. Get in touch with our admissions team to start planning your academic career at UChicago.
ADVERTISEMENT
Tech Briefs
Qiagen's next-gen GI panel debuts in Europe
Qiagen has released its next-generation QIAstat-Dx panel to Europe for use in one-step, fully integrated molecular analysis of gastrointestinal syndromes. The multiplex gastrointestinal panel enables detection of 24 gastrointestinal infections-causing viral, parasitic and bacterial pathogens.
StreetInsider (free content) (10/15) 
LinkedIn Twitter Facebook Google+ Email
Policy Briefs
CMS report: Bundled care initiative participants cut spending
Medicare payments were lower for 50 of 67 Bundled Payments for Care Improvement model clinical episode combinations, and 27 of those payment declines were statistically significant, according to a CMS report. Most of the savings came from reductions in post-acute care utilization, according to the report.
RevCycle Intelligence (10/10) 
LinkedIn Twitter Facebook Google+ Email
FDA issues draft guidance to enhance efficiency in drug development
The FDA on Monday unveiled two new draft guidance documents in an effort to improve the efficiency of the drug development process. The first document addresses the use of minimal residual disease as a biomarker for hematologic malignancy drug development in clinical trials, while the second focuses on regulatory framework pertinent to treatments, such as gene therapies, that address molecular changes that induce or contribute to disease progression.
BioCentury (10/15),  Seeking Alpha (10/15) 
LinkedIn Twitter Facebook Google+ Email
Practice Briefs
FDA approves red blood cell antigen typing test
The FDA has approved Progenika Biopharma's ID Core XT test for non-ABO red blood cell typing before transfusions. The test reports genotypes as final results.
Medscape (free registration) (10/12) 
LinkedIn Twitter Facebook Google+ Email
EU approves Hologic's real-time Bordetella test
European regulators have granted Hologic CE mark approval for the Panther Fusion Bordetella assay, a real-time PCR test that provides detection and differentiation of Bordetella pertussis and Bordetella parapertussis from nasopharynx samples.
FDAnews (10/15) 
LinkedIn Twitter Facebook Google+ Email
Business/Corporate Briefs
Myriad Genetics, Pfizer sign CDx commercialization plan
Myriad Genetics and Pfizer have reached a commercialization plan on promoting the use of Myriad's BRACAnalysis CDx test for determining which patients are suitable for treatment with Pfizer's talazoparib. The companies are expected to collaborate on a number of commercial activities while maintaining responsibility for their respective products.
Seeking Alpha (10/9) 
LinkedIn Twitter Facebook Google+ Email
AACC News
Don't Miss the Point-of-Care Testing Boot Camp and Beyond: Communicating, Connecting and Collaborating 2018 Conference
November 1, 2018 | Portland, OR
Time is running out to register for this event which features presentations from POC experts and interactive, professional skill development.
Call for Scientific Session Proposals
Deadline: 5 p.m. EST (U.S.), November 5, 2018
Submit your cutting-edge, innovative scientific proposals for the 71st AACC Annual Scientific Meeting.
Learn more about AACC:
AACC Homepage | AACC Membership | Annual Meeting
Clinical Laboratory News | Clinical Chemistry | JALM
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Contributing Editor  -  Genna Rollins
Advertising  -  Wynn Hansen
P: 202.470.1149
Editor  -  April Hollis
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2018 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information